COPD: Innovative selective contract according to §140a

„Telementor COPD“ is a new care concept that addresses key gaps in outpatient patient care and thus enables health insurance companies to offer an effective selective contract - evidence-based & scalable. 

Download economic analysis
Spirometer

COPD: Innovative selective contract according to §140a

„Telementor COPD“ is a new care concept that addresses key gaps in outpatient patient care and thus enables health insurance companies to offer an effective selective contract - evidence-based & scalable. 

Spirometer
Download economic analysis

Telementor COPD" care concept"

Telementor COPD" care concept"

At the end of 2025, ZDF reported on the Telementor COPD study at LungenClinic Großhansdorf (et al.) and the care model behind it:

Target group

COPD patients (ICD-10 J44) with at least one exacerbation in the last year, with their own smartphone and connection to pneumological care.

Goals

  • Recognising and treating exacerbations preventively
  • Reduce hospitalisations and re-hospitalisations
  • Improve the health-related quality of life
  • Strengthen coordination between outpatient and inpatient treatment
  • Reduce costs in the healthcare system in the long term

Added value

  • Medical:

Reduction in exacerbations and hospitalisations, stabilisation of the course of the disease, improved quality of life

  • Organisational:

Better cross-sector coordination, relief for medical structures

  • Economical:

Avoidance of cost-intensive inpatient stays, cost-effectiveness, especially for severe COPD

Core elements of the supply

  • Daily recording of relevant vital signs (including respiratory rate, heart rate, oxygen saturation, FEV1, activity)
  • Use of validated sensor technology and a GDPR-compliant app
  • Algorithm-based traffic light system for risk stratification
  • Combination of vital parameters and patient-reported symptoms (COPD Assessment Test)
  • Early identification of clinical deterioration
  •  
  • Continuous review of monitoring data by medical professionals
  • Structured telephone or video-based interventions in the event of anomalies
  • Coordination of prompt appointments with pneumologists or clinics
  • Training and information programmes on the disease, therapy and inhalation technique
  • Movement, breathing and motivation training to promote adherence and activity

Evidence

The Telementor-COPD study, funded by the G-BA Innovation Fund, has shown that the care model outlined here - as part of a multicentre, randomised and controlled clinical study under Consortium management of the LungenClinic Großhansdorf - created scientific evidence. 

The results of the study have been available since the beginning of the year (2026) (Link to the ZDF report). Find out more in our health economic analysis paper. 

Infographic COPD telemonitoring

Download economic analysis

You will receive the link to the analysis paper automatically by e-mail by completing the form:

Telementor_Whitepaper

Download economic analysis

You will receive the link to our analysis paper automatically by e-mail by completing the form:

Whitepaper_Download
  • Telemedical monitoring
  • Daily recording of relevant vital signs (including respiratory rate, heart rate, oxygen saturation, FEV1, activity)
  • Use of validated sensor technology and a GDPR-compliant app
  • Automated triage
  • Algorithm-based traffic light system for risk stratification
  • Combination of vital parameters and patient-reported symptoms (COPD Assessment Test)
  • Early identification of clinical deterioration
  • COPD-Nurse-supported intervention
  • Continuous review of monitoring data by medical professionals
  • Structured telephone or video-based interventions in the event of anomalies
  • Coordination of prompt appointments with pneumologists or clinics
  • Digital patient education & self-management
  • Training and information programmes on the disease, therapy and inhalation technique
  • Movement, breathing and motivation training to promote adherence and activity

3 strategic goals for health insurance companies

3 strategic goals for health insurance companies

1.

Avoid rehospitalisations

2.

Strengthening regional supply

3.

Ensuring quality of care

How SaniQ OS supports you:

How SaniQ OS supports you:

1. avoid rehospitalisation

  • Recognising illness crises at an early stage
  • Automated early warning system for critical vital signs
  • Evidence-based interventions prevent acute events

2. establish cross-sector supply networks

  • Establish scalable, regional supply structures
  • Seamless collaboration between clinic, GP, specialist and nursing service
  • GDPR-compliant communication between all supply stakeholders

3. measurably improve the quality of care

  • Structured documentation for quality reports
  • Evidence generation for health services research
  • Fulfilment of regulatory requirements

Measurable results through structured telemonitoring

Measurable results through structured telemonitoring

Modules & functions
Benefits for clinics
Telemonitoring (vital signs such as blood pressure, weight, FEV1, etc.)
Early detection of complications, reduction of readmissions
Workflow Manager
Structured distribution of tasks between inpatient and outpatient players
Intersectoral communication
GDPR-compliant exchange between inpatient and outpatient stakeholders
Patient app
Greater therapy adherence through active patient involvement
Chat & Televisite
Low-threshold contact for symptoms or questions
HIS interfaces (HL7, FHIR, etc.)
Integration into partners' existing IT infrastructures

What hospital doctors say about SaniQ

"The TIM-NIV study is investigating digital medical options for improving non-invasive home ventilation. SaniQ enables telemedical care for those affected by recording health-related data and transmitting it to the study centre in real time."
Dr Dirk Westhölter
Dr Dirk Westhölter
Clinician Scientist at the Ruhrlandklinik Essen
"We see Qurasoft as a professional and innovation-orientated partner for cross-sector technological solutions within the participating networks."
Dr Daniel Dumitrescu, MD
Deputy Medical Director of the IFAT at the Heart and Diabetes Centre NRW of the University Hospital of the Ruhr University Bochum
"Qurasoft's technical support is simply worth its weight in gold for us, because we are happy to draw on their expertise and vast experience in the areas of IT, development, regulatory affairs, etc. For us, this is the perfect complement to our clinical expertise in the field of rare diseases. "
Dr Maike Stein
Dr Maike Stein
Physician and scientist at the integrated Myasthenia Centre (iMZ) at Charité Universitätsmedizin Berlin

Let's talk about your selective contract!

Jonas Zimmer
- Enterprise Account Executive -

Let's talk about your selective contract!

  • Personal counselling
  • Individual topic focus
  • Discover advantages

Arrange a personal consultation